The South Africa Central Nervous System (CNS) Therapeutic market is expected to reach US$ 3,686.91 Mn in 2027 from US$ 2,267.59 Mn in 2018. The market is estimated to grow with a CAGR of 5.6% from 2019-2027 from 2019-2027.
Rising prevalence of CNS diseases such as malnutrition, malaria, the human immunodeficiency virus & the acquired immune deficiency syndrome (HIV/AIDS), and demographic transitions are expected to surge the market growth. However, high cost of treatment is likely to have a negative impact on the growth of the market in the coming years.
Neurological disorders are very prevalent in Sub-Saharan Africa. The factors responsible for the growing burden include difficult perinatal situations, malnutrition, malaria, the human immunodeficiency virus & the acquired immune deficiency syndrome (HIV/AIDS), and demographic transitions. The primary neurological disorders include mental retardation, cerebral palsy, developmental disorders, epilepsy, peripheral neuropathy, stroke, trauma, and alcohol abuse. According to South African Pharmaceutical Journal in 2016, an estimated 818, 106 people are getting dementia per year, presently affecting more than 4 million people. The number is anticipated to be more than 14 million by 2050. Furthermore, HIV-associated dementia (HAD) is dominant in 15–30% of untreated adults with late-stage disease. The elderly patients, who previously have an increased risk of non-AIDS related dementias, are more prone to untreated HIV. Such a rising prevalence of CNS disorders is expected to create a demand for the central nervous system (CNS) therapeutic across the world.
South Africa Central Nervous System (CNS) Therapeutic market, based on drug type was segmented into analgesics, nervous system drugs, anesthetics, anti-parkinson drugs, anti-epileptics, others. In 2018, the analgesics segment held the largest share of the market, by drug type. This segment is also anticipated to grow at the highest rate during the forecast period because they are used to relive pain which provides relief to patients without being consciousness.
Exhibit: South Africa Drug Type Market Revenue and Forecasts to 2027 (US$ Mn)
South Africa Central Nervous System (CNS) Therapeutic – MARKET SEGMENTATION
By Disease Type
By Drug Type
By Distribution Channel
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 2,267.59 Million |
| Market Size by 2027 | US$ 3,686.91 Million |
| CAGR (2019 - 2027) | 5.6% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Disease Type
|
|
Regions and Countries Covered
|
|
| South Africa | |
| Market leaders and key company profiles |
|
The South Africa Central Nervous System (CNS) Therapeutic Market is valued at US$ 2,267.59 Million in 2018, it is projected to reach US$ 3,686.91 Million by 2027.
As per our report South Africa Central Nervous System (CNS) Therapeutic Market, the market size is valued at US$ 2,267.59 Million in 2018, projecting it to reach US$ 3,686.91 Million by 2027. This translates to a CAGR of approximately 5.6% during the forecast period.
The South Africa Central Nervous System (CNS) Therapeutic Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South Africa Central Nervous System (CNS) Therapeutic Market report:
The South Africa Central Nervous System (CNS) Therapeutic Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South Africa Central Nervous System (CNS) Therapeutic Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South Africa Central Nervous System (CNS) Therapeutic Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For South Africa Central Nervous System (CNS) Therapeutic Market
